Innometry Co., Ltd. (KOSDAQ:302430)
8,660.00
-780.00 (-8.26%)
At close: May 29, 2026
Innometry Revenue
Innometry had revenue of 17.52B KRW in the quarter ending March 31, 2026, with 102.14% growth. This brings the company's revenue in the last twelve months to 47.42B, up 0.02% year-over-year. In the year 2025, Innometry had annual revenue of 38.57B, down -27.23%.
Revenue (ttm)
47.42B
Revenue Growth
+0.02%
P/S Ratio
1.79
Revenue / Employee
282.27M
Employees
168
Market Cap
85.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.57B | -14.43B | -27.23% |
| Dec 31, 2024 | 53.00B | -30.79B | -36.75% |
| Dec 31, 2023 | 83.78B | 8.07B | 10.66% |
| Dec 31, 2022 | 75.71B | 29.24B | 62.92% |
| Dec 31, 2021 | 46.47B | 25.75B | 124.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| THINKWARE | 536.59B |
| SY Dong-A | 395.26B |
| XEXYMIX | 276.36B |
| WITHUS PHARMACEUTICAL Co.,LTD. | 106.44B |
| Kns Co., Ltd | 40.93B |
| Rnt-X | 38.38B |
| SELVAS Healthcare | 30.19B |
| MinTech | 21.02B |